Analyst consensus rating
Haemonetics Analyst Rating: Buy
Direct answer
Haemonetics's consensus rating is Buy.
10 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $122.20.
Forecast evidence checked October 10, 2026.
Get free Haemonetics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $118.69
- Average price target
- $122.20
- High price target
- $140.00
- Low price target
- $86.00
- Low target gap
- -27.5%
- Target upside
- +3%
- High target gap
- +18%
- Target range width
- 45.5%
- Consensus rating
- Buy
- Analysts
- 10
- Evidence date
- October 10, 2026
- Valid through
- October 17, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Haemonetics?
Haemonetics has a verified Buy consensus. The same dataset has an average price target of $122.20.
How far are Haemonetics's low and high targets from the recorded price?
The low target implies -27.5%, while the high target implies +18%.
How many analysts are included in Haemonetics's consensus?
The verified consensus includes 10 analysts.
How is Haemonetics's target upside or downside calculated?
The average target of $122.20 is divided by the recorded price of $118.69, then one is subtracted to produce +3%. This does not guarantee a future return.
When was Haemonetics's analyst forecast verified?
The data was verified on 2026-10-10. The dataset is valid through 2026-10-17.